newsfilter
← Latest News
GlobeNewswire·

Repligen Corporation to Present at Jefferies Global Healthcare Conference

  • Repligen Corporation (NASDAQ: RGEN) announced participation in the Jefferies Global Healthcare Conference in London, UK.
  • Olivier Loeillot, President & CEO, will lead an analyst-led discussion on November 18, 2026, at 2:00 p.m. GMT.
  • A live webcast of the presentation will be available on Repligen's Investor Relations website with limited replay access post-event.
  • Repligen is a global bioprocessing firm that develops technologies to support the manufacturing of biologic drugs for human health.
  • The company serves as a partner to biopharmaceutical developers, manufacturers, & CDMOs to enhance productivity & simplify workflows.
  • Jacob Johnson, VP of Investor Relations, is the designated contact for media inquiries.